EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie (Phase II)Open Access · CC BY 4.0

Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study

Peter J K Tokuda, Takamasa Mitsuyoshi, Yuka Ono, Takahiro Kishi, Yoshiharu Negoro, Setsuko Okumura, Itaru Ikeda, Takashi Sakamoto, Yumi Kokubo, Ryo Ashida, Toshiyuki Imagumbai, Mikiko Yamashita und 9 weitere

Breast Cancer · 2024

DOI: 10.1007/s12282-024-01577-3 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Breast Cancer, 2024. Verfasst von Peter J K Tokuda und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Segmental. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kobe City Medical Center General Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The applicability of ultra-hypofractionated (ultra-HF) whole-breast irradiation (WBI) remains unknown in Japanese women. This study aimed to evaluate the safety and efficacy of this approach among Japanese women and report the results of an interim analysis performed to assess acute adverse events (AEs) and determine whether it was safe to continue this study.

Methods

We enrolled Japanese women with invasive breast cancer or ductal carcinoma in situ who had undergone breast-conserving surgery, were aged ≥ 40 years, had pathological stages of Tis–T3 N0–N1, and had negative surgical margins. Ultra-HF-WBI was delivered at 26 Gy in five fractions over one week. When the number of enrolled patients reached 28, patient registration was paused for three months. The endpoint of the interim analysis was the proportion of acute AEs of grade ≥ 2 (Common Terminology Criteria for Adverse Events v5.0) within three months.

Results

Of the 28 patients enrolled from seven institutes, 26 received ultra-HF-WBI, and 2 were excluded due to postoperative infections. No AEs of grade ≥ 3 occurred. One patient (4%) experienced grade 2 radiation dermatitis, and 18 (69%) had grade 1 radiation dermatitis. The other acute grade 1 AEs experienced were skin hyperpigmentation (n = 10, 38%); breast pain (n = 4, 15%); superficial soft tissue fibrosis (n = 3, 12%); and fatigue (n = 1, 4%). No other acute AEs of grade ≥ 2 were detected.

Conclusions

Acute AEs following ultra-HF-WBI were within acceptable limits among Japanese women, indicating that the continuation of the study was appropriate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMastectomy, SegmentalHumansFemaleMiddle AgedAgedJapanAdultRadiation Dose HypofractionationCarcinoma, Intraductal, NoninfiltratingRadiotherapy, AdjuvantAged, 80 and over

Stichwörter der Autor:innen

Breast cancerInterim analysisPhase II studyUltra-hypofractionated radiation therapyWhole-breast irradiation

Autor:innen und Institutionen

  • Department of Radiation Oncology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.
  • Department of Radiation Oncology, Kobe City Medical Center General Hospital, 2-1-1, Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan. mitsu.t@kuhp.kyoto-u.ac.jp.
  • Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan.
  • Department of Radiation Therapy, Osaka Red Cross Hospital, Osaka, Osaka, Japan.
  • Department of Radiation Oncology, Japanese Red Cross Wakayama Medical Center, Wakayama, Wakayama, Japan.
  • Department of Radiation Oncology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Hyogo, Japan.

Förderung

  • Kobe City Medical Center General Hospital

Zitieren

APA

Tokuda, P. J. K., Mitsuyoshi, T., Ono, Y., Kishi, T., Negoro, Y., Okumura, S., Ikeda, I., Sakamoto, T., Kokubo, Y., Ashida, R., Imagumbai, T., Yamashita, M., Tanabe, H., Takebe, S., Tokiwa, M., Suzuki, E., Yamauchi, C., Yoshimura, M., Mizowaki, T., …, & Kyoto Radiation Oncology Study Group (2024). Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study. Breast Cancer. https://doi.org/10.1007/s12282-024-01577-3

Vancouver

Tokuda PJK, Mitsuyoshi T, Ono Y, Kishi T, Negoro Y, Okumura S, et al. Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study. Breast Cancer. 2024. doi:10.1007/s12282-024-01577-3

BibTeX
@article{Tokuda2024,
  author = {Tokuda, Peter J K and Mitsuyoshi, Takamasa and Ono, Yuka and Kishi, Takahiro and Negoro, Yoshiharu and Okumura, Setsuko and Ikeda, Itaru and Sakamoto, Takashi and Kokubo, Yumi and Ashida, Ryo and Imagumbai, Toshiyuki and Yamashita, Mikiko and Tanabe, Hiroaki and Takebe, Sayaka and Tokiwa, Mariko and Suzuki, Eiji and Yamauchi, Chikako and Yoshimura, Michio and Mizowaki, Takashi and Kokubo, Masaki and Kyoto Radiation Oncology Study Group, Kyoto Radiation Oncology Study Group},
  title = {Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study},
  journal = {Breast Cancer},
  year = {2024},
  doi = {10.1007/s12282-024-01577-3}
}
Kostenlos starten →